Jason Mazzaroth is a Chief Technology Officer at Bound Therapeutics, LLC based in Cherry Hill, New Jersey, United States, North America. With a diverse background in software engineering, molecular dynamics, artificial intelligence, bioinformatics for drug design, and material science, Jason brings a multidisciplinary approach to his role. His early career included the optimization of the TEIRESIAS algorithm, a pivotal tool in biological sequence pattern discovery, where his innovations significantly improved its efficiency and performance. At Bound Therapeutics, Jason leads the development of AI-driven tools to design molecules precisely tailored to specific cellular targets. Under his leadership, the MBD AI platform has achieved significant breakthroughs, including the creation of peptide ligands that target cancer-specific receptors, enabling highly accurate receptor-specific delivery of oligonucleotides. Jason also developed a next-generation sequencing data analysis pipeline, leveraging his expertise to investigate gene expression changes driven by RNA inhibition in cancer. His current focus is on expanding AI-driven design to create targeting ligands for a broader range of receptors, further advancing Bound Therapeutics' cutting-edge therapeutic developments.
Current Position: Chief Technology Officer
Company: Bound Therapeutics, LLC
Location: Cherry Hill, New Jersey, United States, North America
Social: Professional profiles available
Network: Extensive professional connections